Baidu
map

循证医学名词术语中英文双语对照

2010-07-03 MedSci原创 MedSci原创

A安全性 SafetyB半随机对照试验 quasi- randomized control trial,qRCT背景问题 background questions比值比 odds ratio,OR标准化均数差 standardized mean difference, SMD病例报告 case report病例分析 case analysis病人价值观 patient value (此词删除)病人

A
安全性 Safety
B
半随机对照试验 quasi- randomized control trial,qRCT
背景问题 background questions
比值比 odds ratio,OR
标准化均数差 standardized mean difference, SMD
病例报告 case report
病例分析 case analysis
病人价值观 patient value (此词删除)
病人预期事件发生率 patient’s expected event rate, PEER
补充替代医学 complementary and alternative medicine, CAM
不良事件 adverse event
不确定性 uncertainty
C
Cochrane图书馆 Cochrane Library, CL
Cochrane系统评价 Cochrane systematic review, CSR
Cochrane协作网 Cochrane Collaboration, CC
Cox比例风险模型 Cox’ proportional hazard model
参考试验偏倚 References test bias
肠激惹综合征 irritable bowel syndrome,IRB
测量变异 measurement variation
成本-效果 cost-effectiveness
成本-效果分析 cost-effectiveness analysis
成本-效益分析 cost-benefit analysis
成本-效用分析 cost-utility analysis
成本最小化分析(最小成本分析)cost-minimization analysis
重复发表偏倚 Multiple publication bias
传统医学 Traditional Medicine,TM
D
D—L法 DerSimonian & Laird method
发生一例不良反应所需治疗的病例数
the number needed to harm one more patients from the therapy,NNH
对抗疗法 allopathic medicine,AM
对照组中某事件的发生率 control event rate,CER
多重发表偏倚 multiple publication bias (删除此词)
E
二次研究 secondary studies
二次研究证据 secondary research evidence
F
循证医学名词术语中英文对照索引
http://www.jebm.cn/Article_Show.asp?ArticleID=74(第 1/5 页)2005-6-1 21:07:51
循证医学名词术语中英文对照索引
发表偏倚 publication bias
防止1例不良事件发生或得到1例有利结果需要治疗的病例数
number needed to treat,NNT
非随机同期对照试验 non-randomized concurrent control trial
分层随机化 stratified randomization
分类变量 categorical variable
风险(危险度) risk
G
干扰 co-intervention
工作偏倚 Workup bias
固定效应模型 fixed effect model
国际临床流行病学网 International Clinical Epidemiology Network, INCLEN
H
灰色文献 grey literature
后效评价 reevaluation
获益 benefit
J
机会结 chance node
疾病谱偏倚 Spectrum bias
技术特性 Technical properties
加权均数差 weighted mean difference, WMD
假阳性率(误诊率) false positive rate
假阴性率(漏诊率) false negative rate
简单随机化 simple randomization
检索策略 search strategy
交叉对照研究(交叉设计) crossover design
经济学分析 economic analysis
经济学特性 Economic attributes or impacts
经验医学 empirical medicine
精确性 precision
决策结 decision node
决策树分析 decision tree analysis
绝对获益增加率 absolute benefit increase, ABI
绝对危险度降低率 absolute risk reduction, ARR
绝对危险度增加率 absolute risk increase, ARI
K
可重复性 repeatability,reproducibility
可靠性(信度) reliability
可信区间 confidence interval ,CI
可信限 confidence limit ,CL
L
Logistic回归模型 Logistic regression model
历史性对照研究 historical control trial
利弊比 likelihood of being helped vs harmed, LHH
连续性变量 continuous variable
临床对照试验 controlled clinical trial, CCT
临床结局 clinical outcome
临床经济学 clinical economics
临床决策分析 clinical decision analysis
临床流行病学 clinical epidemiology, CE
http://www.jebm.cn/Article_Show.asp?ArticleID=74(第 2/5 页)2005-6-1 21:07:51
循证医学名词术语中英文对照索引
临床实践指南 clinical practice guidelines, CPG
临床试验 clinical trial
临床研究证据 clinical research evidence
临床证据 clinical evidence
临床证据手册 handbook of clinical evidence
零点 Zero time
灵活性 flexibility
临界点 Cut off points
漏斗图 funnel plots
率差(或危险差) rate difference,risk difference,RD
M
Meta- 分析 Meta-analysis
敏感度 sensitivity
敏感性分析 sensitivity analysis
墨克手册 Merck manual
N
脑卒中病房 Stroke Unit
内在真实性 internal validity
P
偏倚 bias
Q
起始队列 inception cohort
前-后对照研究 before-after study
前景问题 foreground questions
区组随机化 block randomization
S
散点图 scatter plots
森林图 forest plots
伤残调整寿命年 disability adjusted life year,DALY
生存曲线 survival curves
生存时间 survival time
生存质量(生活质量) quality of life
世界卫生组织 World Health Organization, WHO
失安全数 fail-Safe Number
试验组某事件发生率 experimental event rate,EER
似然比 likelihood Ratio, LR
适用性 applicability
受试者工作特征曲线(ROC曲线)receiver operator characteristic curve
随机对照临床试验 randomized clinical trials, RCT
随机对照试验 randomized control trial, RCT
随机化隐藏 randomization concealment
随机效应模型 random effect model
T
特异度 specificity
同行评价 colleague evaluation
统计效能(把握度) power
同质性检验 tests for homogeneity
W
http://www.jebm.cn/Article_Show.asp?ArticleID=74(第 3/5 页)2005-6-1 21:07:51
循证医学名词术语中英文对照索引
外在真实性 external validity
完成治疗分析 per protocol,PP
腕管综合征 carpal tunnel syndrome, CTS
卫生技术 health technology
卫生技术评估 health technology assessment, HTA
X
系统评价 systematic review, SR
相对获益增加率 relative benefit increase, RBI
相对危险度 relative risk,RR
相对危险度降低率 relative risk reduction, RRR
相对危险度增加率 relative risk increase, RRI
效果 effectiveness
效力 efficacy
效应尺度 effect magnitude
效应量 effect size
序贯试验 sequential trial
选择性偏倚 selection bias
循证儿科学 evidence-based pediatrics
循证妇产科学 evidence-based gynecology & obstetrics
循证购买 evidence-based purchasing
循证护理 evidence-based nursing
循证决策 evidence-based decision-making
循证内科学 evidence-based internal medicine
循证筛选 evidence-based selection
循证外科学 evidence-based surgery
循证卫生保健 evidence-based health care
循证诊断 evidence-based diagnosis
循证医学 evidence-based medicine, EBM
Y
亚组分析 subgroup analysis
严格评价 critical appraisal
验后比 post-test odds
验后概率 post-test probability
验前比 pre-test odds
验前概率 pre-test probability
阳性预测值 positive predictive value
原始研究 primary studies
异质性检验 tests for heterogeneity
意向治疗分析 intention-to-treat, ITT
阴性预测值 negative predictive value
引用偏倚 citation bias
尤登指数 Youden’s index
语言偏倚 language bias
预后 prognosis
预后因素 prognostic factor
预后指数 prognostic index
原始研究证据 primary research evidence
原始研究证据来源 primary resources
Z
沾染 contamination
真实性(效度) validity
诊断参照标准 reference standard of diagnosis

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1775200, encodeId=e7f21e75200e4, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Dec 31 05:47:00 CST 2010, time=2010-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379422, encodeId=5a9313e9422cd, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379619, encodeId=659113e961929, content=<a href='/topic/show?id=398a3e608cd' target=_blank style='color:#2F92EE;'>#双语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37608, encryptionId=398a3e608cd, topicName=双语)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449625, encodeId=763a14496257a, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616448, encodeId=cd2816164482f, content=<a href='/topic/show?id=5ade6111973' target=_blank style='color:#2F92EE;'>#术语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61119, encryptionId=5ade6111973, topicName=术语)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d519759190, createdName=ms49895894946433513521, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=)]
    2010-12-31 amyloid
  2. [GetPortalCommentsPageByObjectIdResponse(id=1775200, encodeId=e7f21e75200e4, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Dec 31 05:47:00 CST 2010, time=2010-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379422, encodeId=5a9313e9422cd, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379619, encodeId=659113e961929, content=<a href='/topic/show?id=398a3e608cd' target=_blank style='color:#2F92EE;'>#双语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37608, encryptionId=398a3e608cd, topicName=双语)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449625, encodeId=763a14496257a, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616448, encodeId=cd2816164482f, content=<a href='/topic/show?id=5ade6111973' target=_blank style='color:#2F92EE;'>#术语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61119, encryptionId=5ade6111973, topicName=术语)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d519759190, createdName=ms49895894946433513521, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1775200, encodeId=e7f21e75200e4, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Dec 31 05:47:00 CST 2010, time=2010-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379422, encodeId=5a9313e9422cd, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379619, encodeId=659113e961929, content=<a href='/topic/show?id=398a3e608cd' target=_blank style='color:#2F92EE;'>#双语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37608, encryptionId=398a3e608cd, topicName=双语)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449625, encodeId=763a14496257a, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616448, encodeId=cd2816164482f, content=<a href='/topic/show?id=5ade6111973' target=_blank style='color:#2F92EE;'>#术语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61119, encryptionId=5ade6111973, topicName=术语)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d519759190, createdName=ms49895894946433513521, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=)]
    2010-07-05 docwu2019
  4. [GetPortalCommentsPageByObjectIdResponse(id=1775200, encodeId=e7f21e75200e4, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Dec 31 05:47:00 CST 2010, time=2010-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379422, encodeId=5a9313e9422cd, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379619, encodeId=659113e961929, content=<a href='/topic/show?id=398a3e608cd' target=_blank style='color:#2F92EE;'>#双语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37608, encryptionId=398a3e608cd, topicName=双语)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449625, encodeId=763a14496257a, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616448, encodeId=cd2816164482f, content=<a href='/topic/show?id=5ade6111973' target=_blank style='color:#2F92EE;'>#术语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61119, encryptionId=5ade6111973, topicName=术语)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d519759190, createdName=ms49895894946433513521, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=)]
    2010-07-05 xjy04
  5. [GetPortalCommentsPageByObjectIdResponse(id=1775200, encodeId=e7f21e75200e4, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Dec 31 05:47:00 CST 2010, time=2010-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379422, encodeId=5a9313e9422cd, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379619, encodeId=659113e961929, content=<a href='/topic/show?id=398a3e608cd' target=_blank style='color:#2F92EE;'>#双语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37608, encryptionId=398a3e608cd, topicName=双语)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449625, encodeId=763a14496257a, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616448, encodeId=cd2816164482f, content=<a href='/topic/show?id=5ade6111973' target=_blank style='color:#2F92EE;'>#术语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61119, encryptionId=5ade6111973, topicName=术语)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d519759190, createdName=ms49895894946433513521, createdTime=Mon Jul 05 11:47:00 CST 2010, time=2010-07-05, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map